Skip to main content
. Author manuscript; available in PMC: 2024 Apr 25.
Published in final edited form as: J Vasc Access. 2021 May 12;23(6):877–884. doi: 10.1177/11297298211015097

Table 3. Complications and treatment.

Parameter (n) Total cohort (N = 43) Primary difficult cannulation (N1 = 26) Secondary difficult cannulation (N2 = 17) p Value
Complications (n/N, %)
   Pain 16/43 (37.2) 12/26 (46.2) 4/17 (23.5) 0.133
   Hematoma 36/43 (83.7) 20/26 (76.9) 16/17 (94.1) 0.215
   Edema 14/43 (32.6) 12/26 (46.2) 2/17 (11.8) 0.019
   Pseudoaneurysm 1/43 (2.3) 1/26 (3.8) 0 0.413
   Fistula thrombosis 12/43 (27.9) 6/26 (23.1) 6/17 (35.3) 0.492
   Fistula failure 7/43 (16.3) 5/26 (19.2) 2/17 (11.8) 0.685
Treatment Modality (n/N, %) (not mutually exclusive)
   Bridging catheter 29/43 (67.4) 21/26 (80.8) 8/17 (47.1) 0.210
   USG guided cannulation 5/43 (11.6) 4/26 (15.4) 1/17(5.9) 0.633
   Change of cannulation site 10/43 (23.3) 2/26 (7.7) 8/17 (47.1) 0.007
   Closure of AVF 3/43 (7) 3/26 (11.5) 0 0.226
   New AVF creation 3/43 (7) 3/26 (11.5) 0 0.226
   Surgical intervention* 3/43 (7) 2/26 (7.7) 1/17 (5.9) 0.820
   Thrombolysis/angioplasty 11/43 (25.6) 5/26 (19.2) 6/17 (35.3) 0.080
   Accessory vein ligation 4/43 (15.4) 4/26 (15.4) 0 0.038
   Change of RRT modality 3/43 (7) 3/26 (11.5) 0 0.511
   Shifted to peritoneal dialysis 1/43 (2.3) 1/26 (3.8) 0
   Underwent renal transplantation 2/43 (4.6) 2/26 (7.7) 0

AVF: arterio-venous fistula; RRT: renal replacement therapy; USG: ultrasound.

*

Accessory vein ligation not included.